Literature DB >> 21809006

Disturbed Th17/Treg balance in patients with rheumatoid arthritis.

Qian Niu1, Bei Cai, Zhuo-chun Huang, Yun-ying Shi, Lan-lan Wang.   

Abstract

Proinflammatory Th17 cells and CD4(+)CD25(+) regulatory T (Treg) cells are two newly identified T lymphocyte subsets, which have opposite effects on autoimmunity and inflammation. To assess the Th17/Treg pattern and cytokine microenvironment in peripheral blood of patients with RA, we included 66 RA patients and 20 healthy volunteers. Of all these subjects, peripheral Th17 and Treg frequencies were analyzed by flow cytometry (FCM) and the plasma levels of interleukin (IL)-17, 23, 6, tumor necrosis factor (TNF)-α, transforming growth factor (TGF)-β1 were detected by ELISA. The results demonstrated that RA patients revealed an obvious increase in peripheral Th17 frequencies and levels of Th17-related cytokines (IL-17, IL-23, IL-6, TNF-α) while a significant decrease in Treg frequencies and Treg-related cytokine (TGF-β1) levels when compared with healthy people. Our study indicated that development of RA is associated with peripheral Th17/Treg imbalance and characterized by a proinflammatory cytokine microenvironment, which supports continuing generation of Th17 cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21809006     DOI: 10.1007/s00296-011-1984-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.

Authors:  Eva V Acosta-Rodriguez; Giorgio Napolitani; Antonio Lanzavecchia; Federica Sallusto
Journal:  Nat Immunol       Date:  2007-08-05       Impact factor: 25.606

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

3.  Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm.

Authors:  Marie-Christophe Boissier; Eric Assier; Géraldine Falgarone; Natacha Bessis
Journal:  Joint Bone Spine       Date:  2008-06-24       Impact factor: 4.929

Review 4.  T(H)-17 cells in the circle of immunity and autoimmunity.

Authors:  Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2007-04       Impact factor: 25.606

5.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

Review 6.  Disturbed regulatory T cell homeostasis in multiple sclerosis.

Authors:  Koen Venken; Niels Hellings; Roland Liblau; Piet Stinissen
Journal:  Trends Mol Med       Date:  2010-02       Impact factor: 11.951

7.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

Review 8.  The function of interleukin 17 in the pathogenesis of rheumatoid arthritis.

Authors:  Agnieszka Paradowska; Włodzimierz Maślińiski; Agnieszka Grzybowska-Kowalczyk; Jan Łacki
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Sep-Oct       Impact factor: 4.291

Review 9.  IL-17 as a future therapeutic target for rheumatoid arthritis.

Authors:  Wim B van den Berg; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2009-10       Impact factor: 20.543

10.  Biphasic effect of interferon-gamma in murine collagen-induced arthritis.

Authors:  M C Boissier; G Chiocchia; N Bessis; J Hajnal; G Garotta; F Nicoletti; C Fournier
Journal:  Eur J Immunol       Date:  1995-05       Impact factor: 5.532

View more
  88 in total

Review 1.  The genomic landscape of human immune-mediated diseases.

Authors:  Xin Wu; Haiyan Chen; Huji Xu
Journal:  J Hum Genet       Date:  2015-08-20       Impact factor: 3.172

Review 2.  Treg cells in autoimmunity: from identification to Treg-based therapies.

Authors:  Lisa Göschl; Clemens Scheinecker; Michael Bonelli
Journal:  Semin Immunopathol       Date:  2019-04-05       Impact factor: 9.623

3.  Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics.

Authors:  Yang Du; Qiannan Fang; Song-Guo Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Immune cell profiling to guide therapeutic decisions in rheumatic diseases.

Authors:  Joerg Ermann; Deepak A Rao; Nikola C Teslovich; Michael B Brenner; Soumya Raychaudhuri
Journal:  Nat Rev Rheumatol       Date:  2015-06-02       Impact factor: 20.543

5.  Dysregulated ICOS+ proinflammatory and suppressive regulatory T cells in patients with rheumatoid arthritis.

Authors:  Hong-Xia Wang; Xia Kang; Shuai Chu; Haixia Li; Xin Li; Xiaofeng Yin; Yu-Rong Qiu; Weinan Lai
Journal:  Exp Ther Med       Date:  2018-08-24       Impact factor: 2.447

6.  The effect of mesenchymal stem cells on dynamic changes of T cell subsets in experimental autoimmune uveoretinitis.

Authors:  G Li; L Yuan; X Ren; H Nian; L Zhang; Z C Han; X Li; X Zhang
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

7.  Secretory factors produced by adipose mesenchymal stem cells downregulate Th17 and increase Treg cells in peripheral blood mononuclear cells from rheumatoid arthritis patients.

Authors:  Georgi Vasilev; Mariana Ivanova; Ekaterina Ivanova-Todorova; Kalina Tumangelova-Yuzeir; Ekaterina Krasimirova; Rumen Stoilov; Dobroslav Kyurkchiev
Journal:  Rheumatol Int       Date:  2019-04-03       Impact factor: 2.631

8.  Rituximab-induced interleukin-15 reduction associated with clinical improvement in rheumatoid arthritis.

Authors:  César Díaz-Torné; M Angels Ortiz de Juana; Carme Geli; Elisabet Cantó; Ana Laiz; Héctor Corominas; Jordi Casademont; Josep M de Llobet; Cándido Juárez; César Díaz-López; Sílvia Vidal
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

Review 9.  Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases.

Authors:  Shi-Yang Guan; Rui-Xue Leng; Muhammad Imran Khan; Humera Qureshi; Xiang-Pei Li; Dong-Qing Ye; Hai-Feng Pan
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

10.  Expression of tyrosine hydroxylase in CD4+ T cells contributes to alleviation of Th17/Treg imbalance in collagen-induced arthritis.

Authors:  Xiao-Qin Wang; Yan Liu; Huan-Huan Cai; Yu-Ping Peng; Yi-Hua Qiu
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.